Report Detail

Pharma & Healthcare Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Research Report 2021

  • RnM4281963
  • |
  • 18 February, 2021
  • |
  • Global
  • |
  • 93 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Overview

  • 1.1 Product Overview and Scope of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
  • 1.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Type
    • 1.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Serotype 6B
    • 1.2.3 7F Serotype
    • 1.2.4 Serotype 9V
    • 1.2.5 14 Serotype
    • 1.2.6 Serotype 18C
    • 1.2.7 Serotype 19A
    • 1.2.8 19F Serotype
    • 1.2.9 23F Serotype
    • 1.2.10 24F Serotype
    • 1.2.11 Other
  • 1.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Application
    • 1.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Comparison by Application: (2021-2027)
    • 1.3.2 Infants from 6 Weeks to 15 Months Old
    • 1.3.3 Children Aged 15 Months to 5 Years
  • 1.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Estimates and Forecasts
    • 1.4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2016-2027
    • 1.4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2016-2027
    • 1.4.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Region: 2016 Versus 2021 Versus 2027

2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Competition by Manufacturers

  • 2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Sites, Area Served, Product Type
  • 2.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Competitive Situation and Trends
    • 2.5.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players Market Share by Revenue
    • 2.5.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Retrospective Market Scenario by Region

  • 3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
    • 3.3.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
    • 3.3.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
    • 3.4.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
    • 3.4.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region
    • 3.5.2 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
    • 3.6.1 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
    • 3.6.2 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
    • 3.7.2 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historic Market Analysis by Type

  • 4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
  • 4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Type (2016-2021)
  • 4.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Type (2016-2021)

5 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historic Market Analysis by Application

  • 5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
  • 5.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Application (2016-2021)
  • 5.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Pfizer
    • 6.1.1 Pfizer Corporation Information
    • 6.1.2 Pfizer Description and Business Overview
    • 6.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
    • 6.1.5 Pfizer Recent Developments/Updates
  • 6.2 Minhai Bio
    • 6.2.1 Minhai Bio Corporation Information
    • 6.2.2 Minhai Bio Description and Business Overview
    • 6.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
    • 6.2.5 Minhai Bio Recent Developments/Updates
  • 6.3 Kexing Bio
    • 6.3.1 Kexing Bio Corporation Information
    • 6.3.2 Kexing Bio Description and Business Overview
    • 6.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
    • 6.3.5 Kexing Bio Recent Developments/Updates
  • 6.4 Cansino Bio
    • 6.4.1 Cansino Bio Corporation Information
    • 6.4.2 Cansino Bio Description and Business Overview
    • 6.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
    • 6.4.5 Cansino Bio Recent Developments/Updates
  • 6.5 Lanzhou Biological Preparations Institute
    • 6.5.1 Lanzhou Biological Preparations Institute Corporation Information
    • 6.5.2 Lanzhou Biological Preparations Institute Description and Business Overview
    • 6.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
    • 6.5.5 Lanzhou Biological Preparations Institute Recent Developments/Updates

7 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Cost Analysis

  • 7.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
  • 7.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors List
  • 8.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customers

9 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Dynamics

  • 9.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Trends
  • 9.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Growth Drivers
  • 9.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Challenges
  • 9.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Restraints

10 Global Market Forecast

  • 10.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type (2022-2027)
  • 10.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Application (2022-2027)
  • 10.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Serotype 6B
    7F Serotype
    Serotype 9V
    14 Serotype
    Serotype 18C
    Serotype 19A
    19F Serotype
    23F Serotype
    24F Serotype
    Other

    Segment by Application
    Infants from 6 Weeks to 15 Months Old
    Children Aged 15 Months to 5 Years

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Pfizer
    Minhai Bio
    Kexing Bio
    Cansino Bio
    Lanzhou Biological Preparations Institute


    Summary:
    Get latest Market Research Reports on 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13). Industry analysis & Market Report on 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) is a syndicated market report, published as Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Research Report 2021. It is complete Research Study and Industry Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,072.77
    3,109.15
    4,145.53
    2,384.50
    3,576.76
    4,769.01
    308,661.50
    462,992.25
    617,323.00
    213,072.28
    319,608.42
    426,144.56
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report